How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease

Hayato Fujioka, Naoya Kataoka, Teruhiko Imamura*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2227
Number of pages1
JournalInternal Medicine
Volume63
Issue number15
DOIs
StatePublished - 2024

Keywords

  • cardiovascular disease
  • heart failure
  • SGLT2 inhibitor
  • uric acid

ASJC Scopus subject areas

  • Internal Medicine

Cite this